Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC.

The clinical outcome in patients treated with ampicillin-sulbactam may not always be predictable by disc susceptibility testing or with the MIC as determined with a constant level (4 micrograms/ml) of the beta-lactamase inhibitor (MIC1). The enzyme activities (EA) and the MICs estimated at a constan...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Firsov, A A, Savarino, D, Ruble, M, Gilbert, D, Manzano, B, Medeiros, A A, Zinner, S H
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1996
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163189/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8851602/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.3.734
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!